What happened
Tilray Brands, Inc. (NASDAQ: TLRY) reported first-quarter fiscal 2027 net revenue of $257.1 million, up 23% from $209.5 million. Gross profit rose 35% to $77.5 million, and gross margin widened to 30% from 27%. Beverage net revenue climbed 82% to $101.5 million, reflecting the acquisition of BrewDog. EMEA revenue increased 71%, led by medical cannabis, beverage and pharmaceutical distribution.
The company said it reduced outstanding debt by $42 million fiscal year to date and ended the quarter with $221.4 million of cash, restricted cash and marketable securities. Cannabis net revenue was $56.1 million, distribution net revenue was $84.3 million and wellness net revenue was $15.3 million. Gross profit by segment was $42.0 million in beverage, $22.0 million in cannabis, $9.1 million in distribution and $4.4 million in wellness.
Key numbers
| Metric | Latest | Change | Source |
|---|---|---|---|
| Net revenue | $257.1 million | from $209.5 million, +23% | SEC 8-K press release |
| Gross profit | $77.5 million | from $57.5 million, +35% | SEC 8-K press release |
| Gross margin | 30% | from 27%, +300 bps | SEC 8-K press release |
| Beverage net revenue | $101.5 million | from $55.7 million, +82% | SEC 8-K press release |
| Adjusted EBITDA | $9.2 million | from $10.2 million, -10% | SEC 8-K press release |
Read more: Tilray Brands (TLRY) stock analysis and investment case
Why it matters
OptimistFi's case is that Tilray has to show that scale and brand diversification can offset cannabis commoditization and eventually support self-funded cash flow. This filing is mixed for that thesis. Net revenue rose $47.6 million year over year, from $209.5 million to $257.1 million. Gross profit rose $20.0 million, which shows the business is still growing.
But beverage growth reflected BrewDog, and net loss was driven mostly by non-cash charges. Free cash flow was negative $27.45 million, and adjusted free cash flow was negative $23.42 million. The self-funded growth test is still open.
Browse: stock research on every company OptimistFi covers
What's next
Tilray will host a live audio webcast today at 8:30 AM Eastern Time to discuss the results. It reaffirmed fiscal 2027 adjusted EBITDA guidance of $68 million to $75 million.
Management also said results are usually weighted to the second half of the fiscal year, with results strengthening in the fourth quarter. Hitting that range is the next test for the turnaround case.
More from OptimistFi
- TLRY stock: the Tilray Brands thesis, its status and the next test to watch
- Dividendology Explains Hess Midstream LP (NYSE: HESM)'s EBITDA Reset
- Viatris Inc. (NASDAQ: VTRS) Buys Pacira for $1.65 Billion
- Richardson Electronics, Ltd. (NASDAQ: RELL) Margin Gains Need Context
- Stock research on every company OptimistFi covers
- Latest stock research and investment-case updates
- OptimistFi: evidence-first equity research
Sources
- Tilray Brands Q1 fiscal 2027 press release — Quarterly results and guidance issued October 8, 2026
- Tilray Brands Form 8-K — Current report filed October 8, 2026 that attaches the press release
Read the full OptimistFi thesis on Tilray Brands, Inc.: https://optimistfi.com/stocks/TLRY
See what would break the Tilray Brands, Inc. thesis and track it live on the OptimistFi Thesis-Break Engine.
Browse every company OptimistFi covers at optimistfi.com/stocks, or read the latest evidence-first research.
The full Tilray Brands, Inc. investment case, its status and the next test to watch live on the Tilray Brands, Inc. thesis page.
Originally published on OptimistFi, evidence-first equity research. More at optimistfi.com.
